Cart
sales@molnova.com
Lasmiditan succinate
CAS No. 439239-92-6
Lasmiditan succinate( —— )
Catalog No. M21647 CAS No. 439239-92-6
Lasmiditan succinate is a 5-ht (1F) receptor agonist acting on the central nervous system(Ki value of 2.21 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 221 | Get Quote |
|
| 10MG | 333 | Get Quote |
|
| 25MG | 599 | Get Quote |
|
| 50MG | 898 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLasmiditan succinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionLasmiditan succinate is a 5-ht (1F) receptor agonist acting on the central nervous system(Ki value of 2.21 nM).
-
DescriptionLasmiditan succinate is a 5-ht (1F) receptor agonist acting on the central nervous system(Ki value of 2.21 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT
-
Research AreaNeurological Disease
-
IndicationMigraine
Chemical Information
-
CAS Number439239-92-6
-
Formula Weight872.81
-
Molecular FormulaC19H18F3N3O2·0.5(C4H6O4)
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CCC(O)=O.CN1CCC(CC1)C(=O)c1cccc(NC(=O)c2c(F)cc(F)cc2F)n1.CN1CCC(CC1)C(=O)c1cccc(NC(=O)c2c(F)cc(F)cc2F)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Capi M de Andrés Fernando Lionetto L et al. Lasmiditan for the treatment of migraine[J]. Expert Opinion on Investigational Drugs 2017 26(2):227-234.
molnova catalog
related products
-
CP-809101 hydrochlor...
CP-809101 hydrochloride is a potent and selective 5-HT2C receptor agonist (pEC50: 9.96/7.19/6.81 for human 5-HT2C/5-HT2B/5-HT2A receptors).
-
SB 203186 hydrochlor...
SB 203186 hydrochloride is a potent 5-HT4 receptor antagonist.
-
NLX-204 hydrochlorid...
NLX-204 hydrochloride is a potent and selective ERK1/2 phosphorylation-preferring serotonin 5 HT1A receptor agonist(pKi = 10.19).NLX-204, displayed high selectivity in the SafetyScreen44 panel (including hERG channel), high solubility, metabolic stability, and Caco-2 penetration and did not block CYP3A4, CYP2D6 isoenzymes, or P-glycoprotein.
